
Anti-Tumor Effects of Gilteritinib on FLT3 Mutations: Insights into Resistance Mechanisms in Ba/F3 Cell Models
Introduction Acute myeloid leukemia (AML) is a complex, evolving disease involving multiple somatic driver mutations, with patients often harboring more than one mutation.1 Indeed, Papaemmanuil et al identified approximately 5300 driver mutations across 76 …